Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Testing a Remote Sleep Therapy for Insomnia in Ulcerative Colitis

Tests an online sleep therapy adapted for adults with ulcerative colitis and insomnia.

Plain-language title generated from the registry record
Registry title: Piloting an Insomnia Treatment in Patients With Ulcerative Colitis

Key facts

Where
Lebanon, United StatesSee the site

Where in United States

  • Dartmouth Hitchcock Medical CenterLebanon, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Dartmouth-Hitchcock Medical Center
Trial code
NCT07428629
Record updated
28 August 2026
Original description
The goal of this clinical trial is to learn if telehealth-based Cognitive Behavioral Therapy for Insomnia (CBT-I) adapted for Ulcerative Colitis (UC) works to treat insomnia in adults with UC. The main questions it aims to answer are:Read full original descriptionShow less

Piloting an Insomnia Treatment in Patients With Ulcerative Colitis

The goal of this clinical trial is to learn if telehealth-based Cognitive Behavioral Therapy for Insomnia (CBT-I) adapted for Ulcerative Colitis (UC) works to treat insomnia in adults with UC. The main questions it aims to answer are:

* Is telehealth-based CBT-I adapted for UC feasible and acceptable to participants? * Does CBT-I for UC impact insomnia severity and sleep continuity?

Participants will:

* Answer questionnaires online before and after treatment * Complete an online daily sleep diary before, during, and after treatment * Participate in 5 telehealth treatment visits over 7-8 weeks * Participate in 5-10-minute phone calls between treatment visits

Inclusion: Active UC based on PRUCSI; Insomnia Severity Index score > 8 and SOL or WASO > 30 minutes; Stability of sleep \& UC meds for > 3 months; Access to internet or cell phone service sufficient for telehealth.

Exclusion: Current systemic corticosteroid use; Unstable major psychiatric condition (e.g., bipolar disorder, psychotic disorder); Diagnosis of seizure disorder; Diagnosis of restless leg syndrome or positive Cambridge-Hopkins RSLq screen; PHQ-9 depression score > 15; GAD-7 anxiety score > 15; Current alcohol or substance abuse; Current opioid use for pain control; Current pregnancy or nursing; Ileostomy or colostomy; Diagnosis of sleep apnea; Night shift, rotating shift work, or frequent travel outside of time zone; Residence in a state where we cannot conduct telehealth visits.

ClinicalTrials.gov NCT07428629